반응식
C([NH:8][C@H:9]([C:14]([NH:16][C:17]1[CH:18]=[C:19]2[C:27](=[CH:28][CH:29]=1)[C:26]1[S:25][C:24]([C:30]#N)=[N:23][C:22]=1[CH:21]=[CH:20]2)=[O:15])[CH2:10][CH:11]([CH3:13])[CH3:12])(OC(C)(C)C)=O.C1(SC)C=CC=CC=1.FC(F)(F)C(O)=O.O.Cl.[NH2:49][C@@H:50]([C:53]([OH:55])=[O:54])[CH2:51][SH:52].C(=O)([O-])[O-].[K+].[K+]>C(Cl)Cl>[NH2:8][C@H:9]([C:14]([NH:16][C:17]1[CH:18]=[C:19]2[C:27](=[CH:28][CH:29]=1)[C:26]1[S:25][C:24]([C:30]3[S:52][CH2:51][CH:50]([C:53]([OH:55])=[O:54])[N:49]=3)=[N:23][C:22]=1[CH:21]=[CH:20]2)=[O:15])[CH2:10][CH:11]([CH3:12])[CH3:13]참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
7-(Boc-leucinyl)aminonaphtho[2,1-d]thiazole-2-carbonitrile (69 mg, 0.16 mmol) was combined with 0.5 mL of thioanisole and 1.5 mL of DCM and stirred in an ice bath. Trifluoroacetic acid (1.5 mL) was added, and the reaction monitored by HPLC. After 1 h, solvents were removed under reduced pressure, and the remaining residue triturated with ether. The resulting solid was taken up in MeCN/H2O and treated with D-cysteine hydrochloride hydrate (55 mg, 0.31 mmol) and potassium carbonate (55 mg, 0.40 mmol). After 20 min, the reaction was filtered and the product was isolated by preparative HPLC eluting with 2→50% MeCN in 0.1% formic acid. Calcd for C21H23N4O3S2 (M+H): 443.1. found 443.
후처리
- customsolvents were removed under reduced pressure
- customthe remaining residue triturated with ether
- waitAfter 20 min
- filtrationthe reaction was filtered
- customthe product was isolated by preparative HPLC
- washeluting with 2→50% MeCN in 0.1% formic acid
출처 및 근거
- ORD 기록
- ord-3f81971b3c1a40db94d050ff4c49361c
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09447450B2
연결된 노트
불러오는 중…